Strategic Financial Concepts LLC Invests $1.31 Million in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Strategic Financial Concepts LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,968 shares of the company’s stock, valued at approximately $1,312,000. Strategic Financial Concepts LLC owned about 0.20% of iShares U.S. Pharmaceuticals ETF at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Pallas Capital Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at $3,829,000. Southern Capital Advisors LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 1.1% during the third quarter. Southern Capital Advisors LLC now owns 40,280 shares of the company’s stock worth $2,844,000 after purchasing an additional 448 shares during the period. Thrivent Financial for Lutherans lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 23.6% during the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock valued at $2,295,000 after purchasing an additional 6,214 shares during the last quarter. Patten & Patten Inc. TN boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 9.5% in the 3rd quarter. Patten & Patten Inc. TN now owns 25,813 shares of the company’s stock valued at $1,823,000 after purchasing an additional 2,245 shares during the period. Finally, Spinnaker Trust increased its stake in iShares U.S. Pharmaceuticals ETF by 11.2% in the 3rd quarter. Spinnaker Trust now owns 18,154 shares of the company’s stock worth $1,282,000 after purchasing an additional 1,830 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

NYSEARCA IHE opened at $70.05 on Tuesday. iShares U.S. Pharmaceuticals ETF has a 1 year low of $62.67 and a 1 year high of $72.94. The stock’s 50-day moving average price is $67.38 and its two-hundred day moving average price is $69.13. The company has a market cap of $707.51 million, a PE ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.